FDA Commissioner Stephen Hahn testifies before the Senate Health, Education, Labor and Pensions (HELP) Committee hearing on Capitol Hill in Washington, D.C. on June 30, 2020 in Washington, D.C. Photo by KEVIN DIETSCH/POOL/AFP via Getty Images

FDA head says agency won’t cut corners in studying COVID-19 vaccine candidates

Health

WASHINGTON — The head of the Food and Drug Administration says vaccine developers will be expected to study COVID-19 shots in racial minorities, the elderly, pregnant women and those with other health conditions.

FDA Commissioner Stephen Hahn outlined the guidelines for potential vaccines at a Senate hearing on reopening schools and workplaces.

Hahn says "while the FDA is committed to help expedite this work, we will not cut corners in our decision-making."

The agency has come under criticism for granting emergency authorization to a malaria drug touted by President Donald Trump as a treatment for coronavirus. The agency revoked that designation earlier this month after studies found the drug was ineffective against the virus.

The U.S. is set to begin a 30,000-person trial of a government-created shot starting next month. Under the Trump administration's program dubbed "Operation Warp Speed," health officials aim to have 300 million doses on hand by January.

About 15 experimental COVID-19 vaccines are in various stages of testing worldwide. There is no guarantee that any will prove effective.

Support PBS News Hour

Your tax-deductible donation ensures our vital reporting continues to thrive.

FDA head says agency won’t cut corners in studying COVID-19 vaccine candidates first appeared on the PBS News website.

Additional Support Provided By: